en

PRODUCT DETAIL

Alecensa 150 mg tvrdé kapsuly

Code 3040C
MA number EU/1/16/1169/001
Product Form: cps dur 224 (4x56)x150 mg (blis.PA/Al/PVC/Al)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E Protein kinase inhibitors
L01ED Anaplastic lymphoma kinase (ALK) inhibitors
L01ED03 Alectinib
Shelf life: 60
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 16.02.2017
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 15.08.2022
eu-flag.png sk-flag.png